Dalim BioTech Co., Ltd.   Report issue

For profit Phase 1 Phase 3
Founded: Seoul Korea, Republic of (2001)
Status: No NME R&D (2001)

Organization Overview

First Clinical Trial
2013
NCT01780051
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2013

Timeline

NOW
  • Now